SLC26A7

gene
On this page

Also known as SUT2

Summary

SLC26A7 (solute carrier family 26 member 7, HGNC:14467) is a protein-coding gene on chromosome 8q21.3, encoding Anion exchange transporter (Q8TE54). Acts as an anion channel mediating the transport of chloride, sulfate and oxalate ions.

This gene is one member of a family of sulfate/anion transporter genes. Family members are well conserved in gene structure and protein length yet have markedly different tissue expression patterns. This gene has abundant and specific expression in the kidney. Alternatively spliced transcript variants that encode different isoforms have been described.

Source: NCBI Gene 115111 — RefSeq curated summary.

At a glance

  • Gene–disease (curated): congenital hypothyroidism (Strong, GenCC)
  • GWAS associations: 7
  • Clinical variants (ClinVar): 123 total — 1 pathogenic, 3 likely-pathogenic
  • MANE Select transcript: NM_052832

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:14467
Approved symbolSLC26A7
Namesolute carrier family 26 member 7
Location8q21.3
Locus typegene with protein product
StatusApproved
AliasesSUT2
Ensembl geneENSG00000147606
Ensembl biotypeprotein_coding
OMIM608479
Entrez115111

Gene structure

Transcript identifiers

Ensembl transcripts: 15 — 12 protein_coding, 2 protein_coding_CDS_not_defined, 1 nonsense_mediated_decay

ENST00000276609, ENST00000309536, ENST00000517930, ENST00000520249, ENST00000520818, ENST00000522181, ENST00000522862, ENST00000523719, ENST00000617078, ENST00000617233, ENST00000906535, ENST00000906536, ENST00000906537, ENST00000906538, ENST00000953486

RefSeq mRNA: 4 — MANE Select: NM_052832 NM_001282356, NM_001282357, NM_052832, NM_134266

CCDS: CCDS6254, CCDS6255, CCDS75765

Canonical transcript exons

ENST00000276609 — 19 exons

ExonStartEnd
ENSE000009808469131821691318380
ENSE000009808479133429591334447
ENSE000010245879133815091338232
ENSE000011320989139506291398155
ENSE000011323779124953991249844
ENSE000011688069129553191295703
ENSE000011688179128913691289246
ENSE000011688269124931991249413
ENSE000035028119135181091351887
ENSE000035168009139393691394039
ENSE000035291479136658091366717
ENSE000035764729135290191352996
ENSE000035844829136978591369833
ENSE000035865289134040491340551
ENSE000036243629134335391343466
ENSE000036379549139379791393851
ENSE000036853119136347291363538
ENSE000036861439136235391362459
ENSE000036939739138933891389438

Expression profiles

Bgee: expression breadth ubiquitous, 178 present calls, max score 98.89.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 2.5729 / max 1316.4689, expressed in 86 samples.

FANTOM5 promoters (3 alternative TSS)

Promoter IDTPM avgSamples expressed
897362.537284
897350.02335
897370.01244

Top tissues by expression

251 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
thyroid glandUBERON:000204698.89gold quality
right lobe of thyroid glandUBERON:000111998.83gold quality
left lobe of thyroid glandUBERON:000112098.71gold quality
pigmented layer of retinaUBERON:000178294.27gold quality
retinaUBERON:000096694.25gold quality
kidney epitheliumUBERON:000481993.62gold quality
renal medullaUBERON:000036293.27gold quality
kidneyUBERON:000211387.51gold quality
adult mammalian kidneyUBERON:000008286.88gold quality
metanephros cortexUBERON:001053386.82gold quality
cortex of kidneyUBERON:000122584.86gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047379.74silver quality
metanephrosUBERON:000008179.25gold quality
endometriumUBERON:000129577.05gold quality
lymph nodeUBERON:000002974.80gold quality
placentaUBERON:000198771.46gold quality
ventricular zoneUBERON:000305370.18gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099169.34gold quality
body of stomachUBERON:000116168.18gold quality
stomachUBERON:000094567.80gold quality
ganglionic eminenceUBERON:000402363.97gold quality
embryoUBERON:000092263.96gold quality
uterusUBERON:000099563.53gold quality
hindlimb stylopod muscleUBERON:000425263.08gold quality
calcaneal tendonUBERON:000370162.61gold quality
gall bladderUBERON:000211062.47gold quality
right coronary arteryUBERON:000162560.52gold quality
fundus of stomachUBERON:000116060.32gold quality
rectumUBERON:000105258.90gold quality
cardiac muscle of right atriumUBERON:000337958.69silver quality

Single-cell (SCXA)

Detected in 4 experiment(s), a significant marker in 4.

ExperimentMarker?Max mean expression
E-GEOD-131882yes8089.07
E-CURD-119yes6270.68
E-CURD-135yes2892.66
E-ANND-3yes5.84

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

177 targeting SLC26A7, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-3163100.0077.238605
HSA-MIR-1277-5P100.0073.955056
HSA-MIR-4692100.0067.322066
HSA-MIR-5692A100.0074.406850
HSA-MIR-3646100.0073.565283
HSA-MIR-9-5P100.0072.282361
HSA-MIR-3924100.0072.092394
HSA-LET-7A-3P100.0074.033932
HSA-LET-7B-3P100.0074.083913
HSA-LET-7F-1-3P100.0074.023928
HSA-MIR-98-3P100.0074.083907
HSA-MIR-188-3P100.0068.761240
HSA-MIR-33A-5P99.9968.621055
HSA-MIR-33B-5P99.9968.581062
HSA-MIR-548C-3P99.9974.017587
HSA-MIR-451499.9967.101870
HSA-MIR-118499.9968.191458
HSA-MIR-366299.9973.825684
HSA-MIR-428299.9975.366408
HSA-MIR-511-3P99.9968.851467
HSA-MIR-548AW99.9972.573559
HSA-MIR-477599.9875.006394
HSA-MIR-19A-3P99.9875.332762
HSA-MIR-19B-3P99.9875.442754
HSA-MIR-103A-3P99.9869.141595
HSA-MIR-10799.9869.141595
HSA-MIR-520D-5P99.9873.344883
HSA-MIR-524-5P99.9873.434882
HSA-MIR-548P99.9872.253784
HSA-MIR-3065-5P99.9771.563281

Literature-anchored findings (GeneRIF, showing 8)

  • the molecular cloning from human HEVEC of a 2.9-kb cDNA encoding SLC26A7, a novel member of the SLC26 (solute carrier 26) sulfate/anion exchanger family (PMID:11829495)
  • In human kidney SLC26A6 and A7 have a distinct, partially overlapping expression in distal segments of nephrons. The distribution partly differs from that found previously in rodent kidneys. (PMID:15956810)
  • The trafficking to the cell surface suggests novel functional upregulation of SLC26A7 in states that are associated with hypokalemia or increased medullary tonicity. (PMID:16524946)
  • SLC26A7 mutations appear to be associated with thyroid dyshormonogenesis. (PMID:29546359)
  • Study reports homozygous truncating mutations in SLC26A7 in 6 unrelated families with goitrous congenital hypothyroidism and shows that goitrous hypothyroidism also occurs in Slc26a7-null mice. (PMID:30333321)
  • SLC26A7 constitutes the thiocyanate-selective anion conductance of the basolateral membrane of the retinal pigment epithelium. (PMID:32726161)
  • Relationships between SLC26A7 expressions and extra-thyroid metastasis of papillary thyroid carcinoma. (PMID:34593695)
  • Alterations in SLC4A2, SLC26A7 and SLC26A9 Drive Acid-Base Imbalance in Gastric Neuroendocrine Tumors and Uncover a Novel Mechanism for a Co-Occurring Polyautoimmune Scenario. (PMID:34944008)

Cross-species orthologs

10 orthologs

OrganismSymbolGene ID
mus_musculusSlc26a7ENSMUSG00000040569
rattus_norvegicusSlc26a7ENSRNOG00000006096
drosophila_melanogasterPrestinFBGN0036770
caenorhabditis_elegansWBGENE00010788
caenorhabditis_elegansWBGENE00010789
caenorhabditis_elegansWBGENE00012259
caenorhabditis_elegansWBGENE00013963
caenorhabditis_elegansWBGENE00017464
caenorhabditis_elegansWBGENE00018283
caenorhabditis_eleganssulp-6WBGENE00020914

Paralogs (9): SLC26A4 (ENSG00000091137), SLC26A3 (ENSG00000091138), SLC26A8 (ENSG00000112053), SLC26A1 (ENSG00000145217), SLC26A2 (ENSG00000155850), SLC26A5 (ENSG00000170615), SLC26A9 (ENSG00000174502), SLC26A11 (ENSG00000181045), SLC26A6 (ENSG00000225697)

Protein

Protein identifiers

Anion exchange transporterQ8TE54 (reviewed: Q8TE54)

Alternative names: Solute carrier family 26 member 7

All UniProt accessions (5): Q8TE54, A0A087WZI7, E5RFH2, E5RGL8, H0YB61

UniProt curated annotations — full annotation on UniProt →

Function. Acts as an anion channel mediating the transport of chloride, sulfate and oxalate ions. Mediates the transport of bromide, iodide, nitrate, gluconate, thiocyanate and bicarbonate ions. Its permeability towards bicarbonate is weak and increases when pH is above 7. Mediates thiocyanate transport in retinal pigment epithelium cells. Mediates iodide transport in the thyroid gland, playing an important role in the synthesis of thyroid hormones and the maintenance of thyroid function. Although it is an anion channel, according to PubMed:12736153 and PubMed:32119864 it has been shown to exhibit chloride-bicarbonate exchanger activity.

Subcellular location. Cell membrane. Basolateral cell membrane. Recycling endosome membrane. Apical cell membrane. Lateral cell membrane.

Tissue specificity. Expressed in the thyroid gland (at protein level). Expressed in tonsillar high endothelial venule endothelial cells (HEVEC), placenta and in testis, expressed in a subgroup of basal cells in the epididymal ducts.

Disease relevance. Disease-causing variants in SLC26A7 have been found in patients with thyroid dyshormonogenesis and congenital goitrous hypothyroidism.

Activity regulation. Is active at both alkaline and acidic pH. Activity is inhibited by 4,4’-Di-isothiocyanatostilbene-2,2’-disulfonic acid (DIDS - an inhibitor of several anion channels and transporters).

Induction. Up-regulated by hyperosmolarity and down-regulated by acidic pH.

Similarity. Belongs to the SLC26A/SulP transporter (TC 2.A.53) family.

Isoforms (2)

UniProt IDNamesCanonical?
Q8TE54-11, 1A, 1Byes
Q8TE54-22, B

RefSeq proteins (4): NP_001269285, NP_001269286, NP_439897, NP_599028 (=MANE)

Domains & families (InterPro)

IDNameType
IPR001902SLC26A/SulP_famFamily
IPR002645STAS_domDomain
IPR011547SLC26A/SulP_domDomain
IPR036513STAS_dom_sfHomologous_superfamily

Pfam: PF00916, PF01740

Catalyzed reactions (Rhea), 10 shown:

  • hydrogencarbonate(in) = hydrogencarbonate(out) (RHEA:28695)
  • chloride(in) = chloride(out) (RHEA:29823)
  • nitrate(in) = nitrate(out) (RHEA:34923)
  • sulfate(in) = sulfate(out) (RHEA:34983)
  • iodide(out) = iodide(in) (RHEA:66324)
  • hydrogencarbonate(in) + chloride(out) = hydrogencarbonate(out) + chloride(in) (RHEA:72363)
  • thiocyanate(in) = thiocyanate(out) (RHEA:75347)
  • bromide(in) = bromide(out) (RHEA:75383)
  • D-gluconate(in) = D-gluconate(out) (RHEA:76139)
  • oxalate(in) = oxalate(out) (RHEA:76199)

UniProt features (32 total): topological domain 11, transmembrane region 11, sequence variant 4, sequence conflict 2, chain 1, domain 1, region of interest 1, splice variant 1

Structure

Experimental structures (PDB)

2 structures.

PDBMethodResolution (Å)
9IKVELECTRON MICROSCOPY3.1
9IKXELECTRON MICROSCOPY3.2

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q8TE54-F180.770.43

Function

Pathways and Gene Ontology

Reactome pathways

4 pathways

IDPathway
R-HSA-427601Inorganic anion exchange by SLC26 transporters
R-HSA-382551Transport of small molecules
R-HSA-425393
R-HSA-425407SLC-mediated transmembrane transport

MSigDB gene sets: 191 (showing top): RNGTGGGC_UNKNOWN, GOBP_PHENOL_CONTAINING_COMPOUND_METABOLIC_PROCESS, GOBP_DIGESTION, GOBP_ACID_SECRETION, GOBP_REGULATION_OF_HORMONE_LEVELS, GOBP_INORGANIC_ANION_TRANSPORT, GOBP_THYROID_HORMONE_METABOLIC_PROCESS, RACCACAR_AML_Q6, FOXO4_01, FOXO1_01, CHX10_01, GOBP_ORGANIC_ACID_TRANSPORT, NKX61_01, GOBP_CHLORIDE_TRANSPORT, MARTINEZ_RB1_TARGETS_DN

GO Biological Process (14): gastric acid secretion (GO:0001696), thyroid hormone generation (GO:0006590), monoatomic ion transport (GO:0006811), chloride transport (GO:0006821), bicarbonate transport (GO:0015701), iodide transport (GO:0015705), nitrate transmembrane transport (GO:0015706), oxalate transport (GO:0019532), gluconate transmembrane transport (GO:0035429), sulfate transmembrane transport (GO:1902358), chloride transmembrane transport (GO:1902476), monoatomic anion transport (GO:0006820), transmembrane transport (GO:0055085), carboxylic acid transmembrane transport (GO:1905039)

GO Molecular Function (7): chloride channel activity (GO:0005254), bicarbonate transmembrane transporter activity (GO:0015106), sulfate transmembrane transporter activity (GO:0015116), oxalate transmembrane transporter activity (GO:0019531), chloride:bicarbonate antiporter activity (GO:0140900), monoatomic anion channel activity (GO:0005253), antiporter activity (GO:0015297)

GO Cellular Component (8): cytoplasm (GO:0005737), endosome (GO:0005768), plasma membrane (GO:0005886), basolateral plasma membrane (GO:0016323), apical plasma membrane (GO:0016324), lateral plasma membrane (GO:0016328), recycling endosome membrane (GO:0055038), membrane (GO:0016020)

Reactome top-level categories

Rollup of top-2 pathways:

CategoryPathways
SLC-mediated transport of inorganic anions1
Transport of small molecules1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
transport3
inorganic anion transport3
transmembrane transport3
cellular anatomical structure3
monoatomic anion transport2
chloride transmembrane transporter activity2
plasma membrane region2
digestive system process1
acid secretion1
thyroid hormone metabolic process1
nitrate import1
dicarboxylic acid transport1
carbohydrate transmembrane transport1
aldonate transmembrane transport1
sulfur compound transport1
chloride transport1
monoatomic anion transmembrane transport1
monoatomic ion transport1
cellular process1
carboxylic acid transport1
monoatomic anion channel activity1
bicarbonate transport1
transmembrane transporter activity1
sulfur compound transmembrane transporter activity1
sulfate transmembrane transport1
dicarboxylic acid transmembrane transporter activity1
oxalate transport1
solute:inorganic anion antiporter activity1
bicarbonate:monoatomic anion antiporter activity1
monoatomic ion channel activity1
monoatomic anion transmembrane transporter activity1
secondary active transmembrane transporter activity1
intracellular anatomical structure1
endomembrane system1
cytoplasmic vesicle1
membrane1
cell periphery1
basal plasma membrane1
apical part of cell1
plasma membrane1

Protein interactions and networks

STRING

1342 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
SLC26A7IYDQ6PHW0659
SLC26A7SLC4A8Q2Y0W8614
SLC26A7SLC4A2P04920602
SLC26A7SLC4A1P02730592
SLC26A7SLC5A5Q92911572
SLC26A7SLC4A9Q96Q91570
SLC26A7DUOXA2Q1HG44559
SLC26A7SLC4A4Q9Y6R1543
SLC26A7SLC4A3P48751476
SLC26A7SLC4A5Q9BY07463
SLC26A7TSHRP16473457
SLC26A7OR5B12Q96R08432
SLC26A7DUOXA1Q1HG43421
SLC26A7SLC13A1Q9BZW2409
SLC26A7SLC4A10Q6U841407

IntAct

2 interactions, top by confidence:

ABTypeScore
SLC26A7TIMM17Bpsi-mi:“MI:0914”(association)0.350

BioGRID (13): SLC26A7 (Positive Genetic), SLC26A7 (Cross-Linking-MS (XL-MS)), SLC26A7 (Cross-Linking-MS (XL-MS)), AMFR (Affinity Capture-MS), ATP1B3 (Affinity Capture-MS), BRD2 (Affinity Capture-MS), ELAC2 (Affinity Capture-MS), GOLM1 (Affinity Capture-MS), HERC2 (Affinity Capture-MS), NPTN (Affinity Capture-MS), ORMDL1 (Affinity Capture-MS), TIMM17B (Affinity Capture-MS), TMEM43 (Affinity Capture-MS)

ESM2 similar proteins: A4IIF2, A8J6J0, B0JZG0, D7PC76, E9Q3M5, G3X939, G5EBK1, O04722, O13134, O88343, P02730, P04919, P23562, P26433, P32847, P58743, P92946, Q02920, Q11180, Q21751, Q22682, Q28362, Q2Y0W8, Q32LP4, Q4R445, Q4U116, Q5DTL9, Q5RAL2, Q6RI88, Q6RVG2, Q6U841, Q7LBE3, Q80ZA5, Q8BU91, Q8JZR6, Q8R2Z3, Q8T5S1, Q8TE54, Q94225, Q99NH7

Diamond homologs: A0FKN5, A4IIF2, A8J6J0, D7PC76, O43511, O70531, P40879, P45380, P50443, P53391, P53392, P58735, P58743, Q5EBI0, Q5RAL2, Q62273, Q65AC2, Q69DJ1, Q7LBE3, Q7T2C4, Q8BU91, Q8CIW6, Q8GYH8, Q8HY59, Q8NG04, Q8R2Z3, Q8TE54, Q924C9, Q99NH7, Q9BEG8, Q9BXS9, Q9EPH0, Q9FY46, Q9GJY3, Q9H2B4, Q9JKQ2, Q9R154, Q9R155, Q9SAY1, Q9WVC8

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

123 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic1
Likely pathogenic3
Uncertain significance96
Likely benign6
Benign1

Top pathogenic / likely-pathogenic (4)

Variant IDHGVSClassification
2164580NM_052832.4(SLC26A7):c.1554dup (p.Phe519fs)Pathogenic
2138395NM_052832.4(SLC26A7):c.1026+1G>ALikely pathogenic
3778828NM_052832.4(SLC26A7):c.974C>A (p.Ala325Asp)Likely pathogenic
828176NM_052832.4(SLC26A7):c.1498C>T (p.Gln500Ter)Likely pathogenic

SpliceAI

4658 predictions. Top by Δscore:

VariantEffectΔscore
8:91249618:GAGAA:Gacceptor_gain1.0000
8:91318210:TCTTA:Tacceptor_loss1.0000
8:91318211:CTTAG:Cacceptor_loss1.0000
8:91318212:TTA:Tacceptor_loss1.0000
8:91318213:TAGGT:Tacceptor_loss1.0000
8:91318214:A:AGacceptor_gain1.0000
8:91318214:AGGT:Aacceptor_gain1.0000
8:91318215:G:GAacceptor_loss1.0000
8:91318215:G:GGacceptor_gain1.0000
8:91318215:GGT:Gacceptor_gain1.0000
8:91318215:GGTG:Gacceptor_gain1.0000
8:91318376:TTTAT:Tdonor_gain1.0000
8:91318377:TTAT:Tdonor_gain1.0000
8:91318378:TAT:Tdonor_gain1.0000
8:91318380:TGT:Tdonor_loss1.0000
8:91318381:G:GAdonor_loss1.0000
8:91318381:G:GGdonor_gain1.0000
8:91318382:TGA:Tdonor_loss1.0000
8:91318383:GAGT:Gdonor_loss1.0000
8:91338134:A:AGacceptor_gain1.0000
8:91338134:AAAT:Aacceptor_gain1.0000
8:91338135:A:Gacceptor_gain1.0000
8:91352899:A:AGacceptor_gain1.0000
8:91352900:G:GGacceptor_gain1.0000
8:91352900:GTGT:Gacceptor_gain1.0000
8:91363471:GA:Gacceptor_gain1.0000
8:91363471:GAGCA:Gacceptor_gain1.0000
8:91363537:GT:Gdonor_gain1.0000
8:91363539:G:GGdonor_gain1.0000
8:91363544:T:Gdonor_gain1.0000

AlphaMissense

4321 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
8:91352913:A:CS411R0.994
8:91352915:C:AS411R0.994
8:91352915:C:GS411R0.994
8:91289144:T:CF68L0.993
8:91289146:T:AF68L0.993
8:91289146:T:GF68L0.993
8:91318297:G:CA187P0.993
8:91318291:G:TG185W0.992
8:91318292:G:AG185E0.992
8:91318298:C:AA187D0.992
8:91318280:C:AA181E0.991
8:91334361:A:CS237R0.991
8:91334363:C:AS237R0.991
8:91334363:C:GS237R0.991
8:91289148:C:AA69D0.988
8:91289178:G:AG79D0.988
8:91249812:G:AG54E0.986
8:91249844:G:AG65R0.986
8:91249844:G:CG65R0.986
8:91343369:G:AG348D0.986
8:91362359:T:AW441R0.986
8:91362359:T:CW441R0.986
8:91295693:G:AG156D0.985
8:91318291:G:AG185R0.984
8:91318291:G:CG185R0.984
8:91352932:T:CL417P0.984
8:91295540:C:AA105D0.983
8:91289147:G:CA69P0.982
8:91289177:G:CG79R0.982
8:91295692:G:CG156R0.982

dbSNP variants (sampled 300 via entrez): RS1000042955 (8:91313382 C>T), RS1000074172 (8:91313022 T>C), RS1000096778 (8:91214661 T>C), RS1000101050 (8:91322995 T>G), RS1000105490 (8:91356943 A>G), RS1000144351 (8:91222858 T>C,G), RS1000165082 (8:91252790 T>C), RS1000173935 (8:91363820 C>G), RS1000196011 (8:91339682 G>C), RS1000205881 (8:91278994 A>G), RS1000222013 (8:91319207 C>A,G), RS1000231313 (8:91241814 A>G), RS1000232508 (8:91382512 A>C,T), RS1000233689 (8:91257064 C>T), RS1000248620 (8:91331480 A>G)

Disease associations

OMIM: gene MIM:608479 | disease phenotypes:

GenCC curated gene-disease

DiseaseClassificationInheritance
congenital hypothyroidismStrongAutosomal recessive

Mondo (1): congenital hypothyroidism (MONDO:0018612)

Orphanet (1): Congenital hypothyroidism (Orphanet:442)

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

7 associations (top):

StudyTraitp-value
GCST001343_11Fat distribution (HIV)2.000000e-06
GCST001343_16Fat distribution (HIV)8.000000e-06
GCST001343_17Fat distribution (HIV)1.000000e-06
GCST003542_6Night sleep phenotypes7.000000e-07
GCST003542_7Night sleep phenotypes1.000000e-06
GCST007269_278Pulse pressure3.000000e-13
GCST011703_89Smoking initiation3.000000e-08

EFO canonical traits (3, from GWAS)

EFO IDTrait name
EFO:0004341body fat distribution
EFO:0005763pulse pressure measurement
EFO:0005670smoking initiation

MeSH disease descriptors (1)

DescriptorNameTree numbers
D003409Congenital HypothyroidismC05.116.099.343.347; C05.116.132.256; C16.320.240.625; C19.297.155; C19.874.482.281

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

GtoPdb / IUPHAR curated pharmacology

(IUPHAR/BPS Guide to Pharmacology — expert-curated)

Target class: transporter — Anion channels

CTD chemical–gene interactions

22 total (human), top 22 by PubMed support.

ChemicalActions (top 5)PubMed papers
Estradioldecreases expression2
Nickeldecreases expression2
Aflatoxin B1decreases methylation, increases expression2
bisphenol Aincreases expression1
cinnamaldehydeincreases expression1
tris(2-butoxyethyl) phosphateaffects expression1
perfluorooctanoic acidincreases expression1
S-(1,2-dichlorovinyl)cysteineaffects response to substance, increases expression1
CGP 52608affects binding, increases reaction1
perfluoro-n-nonanoic acidincreases expression1
perfluorohexanesulfonic acidincreases expression1
(+)-JQ1 compoundincreases expression1
Benzo(a)pyreneincreases mutagenesis1
Lipopolysaccharidesaffects response to substance, increases expression1
Methyl Methanesulfonateincreases expression1
Tobacco Smoke Pollutiondecreases expression1
Tretinoinaffects expression1
8-Bromo Cyclic Adenosine Monophosphateincreases expression1
Asbestos, Serpentinedecreases methylation1
Antirheumatic Agentsincreases expression1
Okadaic Acidincreases expression1
Genisteindecreases expression1

Clinical trials (associated diseases)

24 trials via MONDO — disease-level, not drug-specific.

TrialPhaseStatusTitle
NCT05228184PHASE4TERMINATEDUse of Tirosint®-SOL or Tablet Formulations of Levothyroxine in Pediatric Patients With Congenital Hypothyroidism (CH)
NCT05371262PHASE4COMPLETEDInfluence of Initial Levothyroxine Dose on Neurodevelopmental and Growth Outcomes in Congenital Hypothyroidism
NCT00403390Not specifiedCOMPLETEDGeneric vs. Name-Brand Levothyroxine
NCT00493103Not specifiedCOMPLETEDTG Gene Mutations and Congenital Hypothyroidism
NCT00497575Not specifiedCOMPLETEDDiagnosis and Follow-up of Patients With Subclinical Hypothyroidism
NCT00505479Not specifiedUNKNOWNIodine Status in Pregnant Women and Their Newborns: is Congenital Hypothyroidism Related to Iodine Deficiency in Pregnancy?
NCT01223638Not specifiedWITHDRAWNThe Prevalence of Hearing Loss Among Children With Congenital Hypothyroidism
NCT01349634Not specifiedCOMPLETEDThe Effects of Iodized Salt on Cognitive Development in Ethiopia
NCT01488721Not specifiedCOMPLETEDClinical Evaluation of NeoPlex4 Assay and NeoPlex System
NCT01916018Not specifiedCOMPLETEDClinical and Genetic Analysis in Congenital Hypothyroidism Due to Thyroid Dysgenesis.
NCT02307175Not specifiedCOMPLETEDA Study of 99m Tc Pertechnetate Produced in High Energy Cyclotron in Patients With Thyroid Scan Indication
NCT02374593Not specifiedCOMPLETEDTargeted Levothyroxine Dosing in Infants With Congenital Hypothyroidism
NCT03655223Not specifiedENROLLING_BY_INVITATIONEarly Check: Expanded Screening in Newborns
NCT04712760Not specifiedUNKNOWNCongenital Hypothyroidism in Children With Eutopic Gland or Thyroid Hemiagenesis: Predictive Factors for Transient vs Permanent Hypothyroidism.
NCT04734457Not specifiedUNKNOWNFinal Height in Patients With CH Diagnosed by the Screening
NCT05687474Not specifiedCOMPLETEDBaby Detect : Genomic Newborn Screening
NCT06724224Not specifiedRECRUITINGComparison of Levothyroxine Formulations in the Treatment of Congenital Hypothyroidism
NCT06728735Not specifiedRECRUITINGRole of Next Generation Sequencing in the Etiological Diagnosis of Permanent Congenital Hypothyroidism With in Situ Thyroid
NCT06864039Not specifiedENROLLING_BY_INVITATIONQuality of Life and Long-term Outcome of Adequately Treated Congenital Hypothyroidism
NCT06864351Not specifiedRECRUITINGProspective Evaluation of OptiThyDose
NCT07126353Not specifiedNOT_YET_RECRUITINGMetabolic Risk Assessment in Prepubertal Children With Congenital Hypothyroidism
NCT07280104Not specifiedRECRUITINGInfants With Primary Congenital Hypothyroidism and Development
NCT07425028Not specifiedNOT_YET_RECRUITINGEvaluation of an Intensified Systematic Screening for Congenital Hypothyroidism in Premature Newborns
NCT07579988Not specifiedNOT_YET_RECRUITINGUltrasound Measurement of Thyroid Volume in Term Newborns